Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
132.60    1.20 (0.91%)
Bid:
131.20
Ask:
132.00
Spread: 0.80 (0.61%)
Market Cap: £322.77m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

PureTech News

TRADING UPDATES: Chrysalis backs InfoSum; Argo Blockchain goes green
17 Aug 2021

TRADING UPDATES: Chrysalis backs InfoSum; Argo Blockchain goes green

TRADING UPDATES: Chrysalis backs InfoSum; Argo Blockchain goes green

EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out
13 Aug 2021

EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out

EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out

TRADING UPDATES: Ince launches solution; PureTech gets USD6.5 million
11 Aug 2021

TRADING UPDATES: Ince launches solution; PureTech gets USD6.5 million

TRADING UPDATES: Ince launches solution; PureTech gets USD6.5 million

Director dealings: Puretech Health director raises stake
22 Jul 2021

Director dealings: Puretech Health director raises stake

(Sharecast News) - Puretech Health revealed on Thursday that director Bharatt Chowrira had acquired 25,000 ordinary shares in the FTSE 250-listed biot...

DIRECTOR DEALINGS: Incoming Naked Wines chair buys USD175,000 worth
22 Jul 2021

DIRECTOR DEALINGS: Incoming Naked Wines chair buys USD175,000 worth

DIRECTOR DEALINGS: Incoming Naked Wines chair buys USD175,000 worth

TRADING UPDATES: Fonix Mobile annual earnings grow; MySale cuts costs
21 Jul 2021

TRADING UPDATES: Fonix Mobile annual earnings grow; MySale cuts costs

TRADING UPDATES: Fonix Mobile annual earnings grow; MySale cuts costs

IN BRIEF: PureTech's Gelesis to merge with Capstar ahead of US float
19 Jul 2021

IN BRIEF: PureTech's Gelesis to merge with Capstar ahead of US float

IN BRIEF: PureTech's Gelesis to merge with Capstar ahead of US float

Johnson & Johnson colon inflammation drug sees 55% remission rates
9 Jul 2021

Johnson & Johnson colon inflammation drug sees 55% remission rates

Johnson & Johnson colon inflammation drug sees 55% remission rates